Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1991 Dec;14(6):590-5.

Calcium antagonists and renal hemodynamics: implications for renal protection

Affiliations
  • PMID: 1794210
Review

Calcium antagonists and renal hemodynamics: implications for renal protection

M Epstein. Clin Invest Med. 1991 Dec.

Abstract

Recently, attention has focussed on the effects of calcium antagonists on renal function. When administered in vitro to the isolated perfused kidney, calcium antagonists exhibit consistent actions permitting characterization of their renal hemodynamic effects. Calcium antagonists do not affect the vascular tone of the vasodilated isolated perfused kidney, but they do dramatically reverse the response of this preparation to vasoconstrictor agents. Studies using the isolated hydronephrotic rat kidney model, which permits direct visualization of afferent and efferent arterioles, have demonstrated that calcium antagonists selectively vasodilate preglomerular vessels. The clinical implications of such observations are still being delineated. Nevertheless, the results of preliminary studies in experimental animal models and in human transplant recipients suggest that calcium antagonists exert salutary effects on renal function in clinical settings characterized by impaired renal hemodynamics. Furthermore, a case can be made that these salutary renal hemodynamic effects of calcium antagonists commend their use in the management of essential hypertension.

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

Substances